The Effect of Playful Physiotherapy Intervention

April 28, 2026 updated by: Hanna Kalajas-Tilga, University of Tartu

The Effect of Playful Physiotherapy Intervention on Emotional Self-regulation in Children Aged 7-12 Years Old With Neurodevelopmental and Behavioral Special Needs in a Rehabilitation Setting.

The goal of this quasi-experimental study is to evaluate the changes in emotional, behavioral, and psychosocial functioning of children aged 7-12 following a playful physiotherapy intervention. The study focused on the potential effects of a play- and body-based intervention on children's daily functioning, based on parent-reported assessments

The main question[s] it aims to answer [is/are]:

Participants will be evaluated based on the Strengths and Difficulties Questionnaire and KIDSCREEN-27 before and after the playful physiotherapy intervention programme.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

25

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Hanna Kalajas-Tilga, PhD
  • Phone Number: +37258361041
  • Email: h9kala@gmail.com

Study Locations

      • Tartu, Estonia
        • Recruiting
        • ProVida
        • Contact:
          • Ingrid Tiirats

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age 5-12 years;
  • Clinical diagnosis: ADHD, ASD, behavioral regulation difficulties, and/or social adaptation difficulties in group settings;
  • Participation in physiotherapy at ProVida Clinic or assessment by the clinic's rehabilitation team regarding suitability for participation;
  • Ability to participate in movement- and play-based activities in a group format;
  • Proficiency in Estonian;
  • No prior participation in a similar group.

Exclusion Criteria:

  • Acute or chronic medical condition that prevents active participation;
  • Severe cognitive or sensory impairment that prevents understanding of activities or safe participation;
  • Situations in which the child's participation may disrupt group functioning or compromise safety.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control group
Experimental: Intervention group
Subjects will attend playful physiotherapy sessions

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of life of the participants
Time Frame: Baseline and to the end of the intervention at 6 weeks
Quality of life of the participants is evaluated by their parents using KIDSCREEN-27
Baseline and to the end of the intervention at 6 weeks
Positive and negative aspects of psychosocial functioning of the participants
Time Frame: Baseline and to the end of the intervention at 6 weeks
Positive and negative aspects of participants' psychosocial functioning is evaluated bu their parents using SDQ scale.
Baseline and to the end of the intervention at 6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 1, 2026

Primary Completion (Estimated)

February 1, 2027

Study Completion (Estimated)

February 1, 2027

Study Registration Dates

First Submitted

February 16, 2026

First Submitted That Met QC Criteria

March 6, 2026

First Posted (Actual)

March 12, 2026

Study Record Updates

Last Update Posted (Actual)

May 5, 2026

Last Update Submitted That Met QC Criteria

April 28, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

IPD is considered to make available in the Open Science Foundation website.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Autism Spectrum Disorder

Clinical Trials on Playful physiotherapy programme

Subscribe